LCTX insider filings
Lineage Cell Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-19. Screen LCTX transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 5 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 5 filings by 7 insiders — 1,115,500 shares, $870,998 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: purchase of 1,000,000 shares @ $0.77 ($770,700) by BROADWOOD PARTNERS, L.P., filed 2026-11-19.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| BROADWOOD PARTNERS, L.P. — Director, 10% owner & BROADWOOD CAPITAL INC — 10% owner & Bradsher Neal C — Director, 10% owner | 1 | 2 legs · 1,000,000 sh · $770,700 | — | — |
| Culley Brian M — President and CEO, Director | 1 | 1 leg · 40,500 sh · $37,098 | — | — |
| Mulroy Michael H. — Director | 1 | 1 leg · 30,000 sh · $26,100 | — | — |
| ANDREWS DEBORAH J — Director | 1 | 1 leg · 25,000 sh · $20,000 | — | — |
| Howe Jill Ann — Chief Financial Officer | 1 | 1 leg · 20,000 sh · $17,100 | — | — |
Recent insider filings — Lineage Cell Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | BROADWOOD PARTNERS, L.P. — Director, 10% owner BROADWOOD CAPITAL INC — 10% owner Bradsher Neal C — Director, 10% owner | Purchase (P): 1,000,000 @ $0.77 · Purchase (P): 0 @ $0 | EDGAR |
| 2026-11-19 | 4 | Mulroy Michael H. — Director | Purchase (P): 30,000 @ $0.87 | EDGAR |
| 2026-11-17 | 4 | ANDREWS DEBORAH J — Director | Purchase (P): 25,000 @ $0.80 | EDGAR |
| 2026-11-17 | 4 | Culley Brian M — President and CEO, Director | Purchase (P): 40,500 @ $0.92 | EDGAR |
| 2026-11-16 | 4 | Howe Jill Ann — Chief Financial Officer | Purchase (P): 20,000 @ $0.85 | EDGAR |
| 2026-07-02 | 4 | Amin Dipti — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Jayasuriya Anula — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Russell Angus C. — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Mulroy Michael H. — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | ANDREWS DEBORAH J — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-07-02 | 4 | Bradsher Neal C — Director, 10% owner | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | Culley Brian M — President and CEO, Director | Purchase (P): 15,000 @ $1.62 | EDGAR |
| 2026-03-06 | 4 | Howe Jill Ann — Chief Financial Officer | Grant/award (A): 1,050,000 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Samuel George A. III — General Counsel and Secretary | Grant/award (A): 900,000 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Culley Brian M — President and CEO, Director | Grant/award (A): 3,250,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Samuel George A. III — General Counsel and Secretary | Option exercise (M): 6,075 · Tax withholding (F): 2,502 @ $1.80 · Option exercise (M): 6,075 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Culley Brian M — President and CEO, Director | Option exercise (M): 31,250 · Tax withholding (F): 12,869 @ $1.80 · Option exercise (M): 31,250 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Samuel George A. III — General Counsel and Secretary | Grant/award (A): 1,735 · Tax withholding (F): 65 @ $1.68 | EDGAR |
| 2025-12-19 | 4 | Culley Brian M — President and CEO, Director | Grant/award (A): 8,925 · Tax withholding (F): 334 @ $1.68 | EDGAR |
| 2025-07-03 | 4 | Bradsher Neal C — Director, 10% owner | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Amin Dipti — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Jayasuriya Anula — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Russell Angus C. — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Mulroy Michael H. — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | ANDREWS DEBORAH J — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Howe Jill Ann — Chief Financial Officer | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Samuel George A. III — General Counsel and Secretary | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Culley Brian M — President and CEO, Director | Grant/award (A): 2,300,000 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Samuel George A. III — General Counsel | Option exercise (M): 6,076 · Tax withholding (F): 2,440 @ $0.65 · Option exercise (M): 6,076 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Culley Brian M — President and CEO, Director | Option exercise (M): 31,249 · Tax withholding (F): 12,547 @ $0.65 · Option exercise (M): 31,249 (derivative) @ $0 | EDGAR |
| 2025-01-28 | 4 | BROADWOOD PARTNERS, L.P. — Director, 10% owner BROADWOOD CAPITAL INC — 10% owner BRADSHER NEAL C — Director, 10% owner | Purchase (P): 7,894,737 @ $0.76 · Purchase (P): 0 @ $0 · Purchase (P): 7,894,737 (derivative) @ $0 · Purchase (P): 0 (derivative) @ $0 | EDGAR |
| 2024-11-26 | 4 | Howe Jill Ann — Chief Financial Officer | Purchase (P): 15,000 @ $0.59 | EDGAR |
| 2024-11-26 | 4 | Samuel George A. III — General Counsel | Purchase (P): 15,000 @ $0.60 | EDGAR |
| 2024-11-25 | 4 | Mulroy Michael H. — Director | Purchase (P): 40,000 @ $0.57 | EDGAR |
| 2024-11-22 | 4 | Culley Brian M — President and CEO, Director | Purchase (P): 40,000 @ $0.60 | EDGAR |
| 2024-08-19 | 4 | Howe Jill Ann — Chief Financial Officer | Purchase (P): 10,500 @ $0.89 | EDGAR |
| 2024-07-03 | 4 | Amin Dipti — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Jayasuriya Anula — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Russell Angus C. — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Mulroy Michael H. — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | ANDREWS DEBORAH J — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | BRADSHER NEAL C — Director, 10% owner | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | BAILEY DON M — Director | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | Culley Brian M — President and CEO, Director | Purchase (P): 10,000 @ $1.05 | EDGAR |
| 2024-03-08 | 4 | Howe Jill Ann — Chief Financial Officer | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | Samuel George A. III — General Counsel/Secretary | Grant/award (A): 650,000 (derivative) @ $0 | EDGAR |
| 2024-03-08 | 4 | Culley Brian M — President and CEO, Director | Grant/award (A): 1,900,000 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Samuel George A. III — General Counsel/Secretary | Option exercise (M): 6,076 · Tax withholding (F): 2,490 @ $1.08 · Option exercise (M): 6,076 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | Culley Brian M — President and CEO, Director | Option exercise (M): 31,249 · Tax withholding (F): 12,806 @ $1.08 · Option exercise (M): 31,249 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | BAILEY DON M — Director | Purchase (P): 96,155 @ $1.04 | EDGAR |
Recent 8-K events — Lineage Cell Therapeutics, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-12 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-11 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-28 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-24 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-12 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=LCTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs